Övervikt och fetma
Senast uppdaterad: Senast reviderad:
Sakkunnig:Anna Nager
Definition:
Övervikt definieras som BMI >25, fetma grad I som BMI >30, fetma grad II som BMI >35 och fetma grad III (extrem fetma) som BMI >40.
Förekomst:
Självrapporterad data insamlad under 2014 visar att 14 % av personer >15 år i Sverige har BMI >30, motsvarande definitionen för fetma.
Symtom:
Övervikt samt eventuella tilläggssymtom som sömnsvårigheter, dyspepsi och minskad livskvalitet.
Kliniska fynd:
Övervikt samt eventuella riskfaktorer för hjärt-kärlsjukdom som hypertoni, hyperlipidemi och diabetes typ 2.
Diagnostik:
TSH samt njur- och leverfunktionsprover. Blodfetter och HbA1c för bedömning av risk för hjärt-kärlsjukdom.
Behandling:
Koständring ökad fysisk aktivitet och i undantagsfall läkemedelsbehandling. Kirurgi kan vara aktuellt vid fetma av grad III, eller vid grad II om tilläggssymtom finns.
- World Health Organization. Obesity. Preventing and managing the global epidemic. Report of a WHO consultation on obesity, Geneva, 3-5 June 1997. Genéve: WHO, 1997.
- Eckel RH. Nonsurgical management of obesity in adults. N Engl J Med 2008; 358: 1941-50. PubMed
- Flegal KM, Graubard BI, Williamson DF, Gail MH. Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA 2007; 298: 2028-37. PMID: 17986696 PubMed
- Shanshan L, Shin HJ, Ding EL, van Dam RM. Adiponectin levels and risk of type 2 diabetes. A systematic review and meta-analysis. JAMA 2009; 302: 179-88. PMID: 19584347 PubMed
- Kramer CK, Zinman B, Retnakaran R. Are metabolically healthy overweight and obesity benign conditions? A systematic review and meta-analysis. Ann Intern Med 2013; 159: 758-69. PMID: 24297192 PubMed
- Bennet WL, Gilson MM, Jamshidi R, et al. Impact of bariatric surgery on hypertensive disorders in pregnancy: restrospective analysis of insurance claims data. BMJ 2010; 340: c1662. BMJ (DOI)
- Flynn AC, Dalrymple K, Barr S, et al. Dietary interventions in overweight and obese pregnant women: a systematic review of the content, delivery, and outcomes of randomized controlled trials. Nutr Rev. 2016 May;74(5):312-28. pmid: 27083868. PubMed
- SOreg årsrapport 2017, del 1, hämtad 2019-02-07 www.ucr.uu.se
- Folkhälsans utveckling – årsrapport 2022. Folkhälsomyndigheten www.folkhalsomyndigheten.se
- Mårild S et al. Läkemedelsboken: Övervikt och fetma. : Läkemedelsverket, 2011. www.lakemedelsboken.se
- Övervikt och fetma. Folkhälsomyndigheten. Hämtad 2019-06-25 www.folkhalsomyndigheten.se
- Lissner L, Sohlström A, Sundblom E, Sjöberg A. Trends in overweight and obesity in Swedish schoolchildren 1999–2005: has the epidemic reached a plateau? . Obes Rev. 2010; 11 (8): 553-9. www.ncbi.nlm.nih.gov
- Sjöberg A, Moraeus L, Yngve A, Poortvliet E, Al-Ansari U, Lissner L. Overweight and obesity in a representative sample of schoolchildren – exploring the urban– rural gradient in Sweden. Obes Rev 2011; 12 (5): 305-14. www.ncbi.nlm.nih.gov
- Flegal KM, Kruszon-Moran D, Carroll MD, Fryar CD, Ogden CL. Trends in Obesity Among Adults in the United States, 2005 to 2014. JAMA 2016; 315: 2284-91. pmid:27272580 PubMed
- Haslam DW, James WPT. Obesity. Lancet 2005; 366: 1197-209. PubMed
- Samaha FF, Iqbal N, Seshadri P, et al. A low-carbohydrate as compared with a low-fat diet in severe obesity . N Engl J Med 2003; 348: 2074-81. PubMed
- Reilly JJ, Jackson DM, Montgomery C, Kelly LA, Slater C, Grant S, Paton JY . Total energy expenditure and physical activity in young Scottish children: mixed longitudinal study. Lancet 2004; 363: 211-2. PubMed
- Maruyama K, Sato S, Ohira T. The joint impact on being overweight of self reported behaviours of eating quickly and eating until full: cross sectional survey. BMJ 2008; 337: a2002. BMJ (DOI)
- Brandkvist M, Bjørngaard JH, Ødegård RA et al. Quantifying the impact of genes on body mass index during the obesity epidemic: longitudinal findings from the HUNT Study. BMJ. 2019 Jul 3;366:l4067. PMID: 31270083 PubMed
- Kivimäki M, Lawlor DA, Singh-Manoux A, et al. Common mental disorder and obesity-insight from four repeat measures over 19 years: prospective Whitehall II cohort study. BMJ 2009; 339: b3765. BMJ (DOI)
- Wedderkopp N, Andersen LB, Steen Hansen H, Froberg K. Fedme blant børn. Ugeskr Læger 2001; 163: 2907-12. PubMed
- Heymsfield SB, Wadden TA. Mechanisms, Pathophysiology, and Management of Obesity. N Engl J Med. 2017 Jan 19;376(3):254-266. PMID: 28099824.
- Korner J, Leibel RL. To eat or not to eat - how the gut talks to the brain. N Engl J Med 2003; 349: 926-8. PubMed
- NICE Guidance. Obesity: identification, assessment and management. Last updated 08 September 2022. www.nice.org.uk
- Jacobs EJ, Newton CC, Wang Y, et al. Waist circumference and all-cause mortality in a large US cohort. Arch Intern Med 2010; 170: 1293-301. PubMed
- Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes Rev. 2012 Mar;13(3):275-86. doi: 10.1111/j.1467-789X.2011.00952.x. Epub 2011 Nov 23. PMID: 22106927 PubMed
- Grief SN, Miranda RLF. Weight loss maintenance. Am Fam Physician 2010; 82: 630-34. PMID: 20842990 PubMed
- Shikora SA, Saltzmann E. Revisiting Obesity: Current Treatment strategies. Review. Hospital Medicine 1998; 34(8):41-44, 47-50
- Potter MB, Vu JD, Croughan-Minihane M. Weight management: What patients want from their primary care physicians. J Fam Pract 2001; 50: 513-8. PMID: 11401737 PubMed
- Wadden TA, Butryn ML, Hong PS, et al. Behavioral treatment of obesity in patients encountered in primary care settings: a systematic review. JAMA. 2014 Nov 5;312(17):1779- 91. doi: 10.1001/jama.2014.14173. DOI
- Madigan CD, Graham HE, Sturgiss E, et al. Effectiveness of weight management interventions for adults delivered in primary care: systematic review and meta-analysis of randomised controlled trials. BMJ 2022; 377: e069719. pmid:35636762 PubMed
- Johnson F, Cooke L, Croke H, Wardle J . Changing perceptions of weight in Great Britain: comparison of two population surveys . BMJ 2008; 337: a494. PubMed
- Motiverande samtal för att förändra mat- eller motionsvanor. SBU-kommentar (2014-04-02).
- Shaw K, Gennat H, O'Rourke P et al. Exercise for overweight or obesity. Cochrane Database of Systematic Reviews, issue 4, 2007. The Cochrane Library
- Svendsen OL, Toubro S, Bruun JM, Linnet JP, Kroustrup JP. Retningslinjer for behandling af overvægt/fedme anno 2006. Ugeskr Læger 2006; 168: 180-2. PubMed
- Garrow JS, Summerbell CD. Meta-analysis: effect of exercise with or without dieting, on body composition of overweight subjects. Eur J Clin Nutr 1995; 49: 1-10. PubMed
- Sacks FM, Bray GA, Carey VJ, et al. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med 2009; 360: 859-73. New England Journal of Medicine
- Liu D, Huang Y, Huang C, et al. Calorie Restriction with or without Time-Restricted Eating in Weight Loss. N Engl J Med 2022; 386: 1495-1504. pmid:35443107 PubMed
- Lowe DA, Wu N, Rohdin-Bibby L, et al. Effects of Time-Restricted Eating on Weight Loss and Other Metabolic Parameters in Women and Men With Overweight and Obesity: The TREAT Randomized Clinical Trial. JAMA Intern Med 2020; 180: 1491-99. pmid:32986097 PubMed
- Jamshed H, Steger FL, Bryan DR, Richman JS, Warriner AH, Hanick CJ, Martin CK, Salvy SJ, Peterson CM. Effectiveness of Early Time-Restricted Eating for Weight Loss, Fat Loss, and Cardiometabolic Health in Adults With Obesity: A Randomized Clinical Trial. JAMA Intern Med. 2022 Sep 1;182(9):953-962. doi: 10.1001/jamainternmed.2022.3050. PMID: 35939311 PubMed
- Johnston BC, Kanters S, Bandayrel K, et al. Comparison of weight loss among named diet programs in overweight and obese adults: a meta-analysis. JAMA 2014; 312: 923-33. pmid:25182101 PubMed
- Astrup A, Larsen TM, Harper A. Atkins and other low-carbohydrate diets: hoax or an effective tool for wieght loss?. Lancet 2004; 364: 897-99. PubMed
- Foster GD, Wyatt HR, Hill JO. Weight ant meetabolic outcomes after 2 years on a low-carbohydrate versus low-fat diet: a randomized trial. Ann Intern Med 2010; 153: 147-57. Annals of Internal Medicine
- Larsen TM, Dalskov S-M, van Baak M, et al. Diets with high or low protein content and glycemic index for weight-loss maintenance. N Engl J Med 2010; 363: 2102-13. New England Journal of Medicine
- Pittler MH, Ernst E. Dietary supplements for body-weight reduction: a systematic review. Am J Clin Nutr 2004; 79: 529-36. PubMed
- Boutelle KN, Kirschenbaum DS. Further support for consistent self-monitoring as a vital component of successful weight control. Obes Res 1998; 6: 219-24. PubMed
- Kayman S, Bruvold W, Stern JS. Maintenance and relapse after weight loss in women: behavioral aspects. Am J Clin Nutr 1990; 52:800-7. PubMed
- Nationella riktlinjer för vård vid obesitas. Socialstyrelsen (hämtad 2022-05-09) www.socialstyrelsen.se
- Rucker D, Padwal R, Li SK, et al. Long term pharmacotherapy for obesity and overweight: updateed metaanlysis. BMJ 2007; 335: 1194-9. British Medical Journal
- Lindgarde F, on behalf of the Orlistat Swedish Multimorbidity Study Group. The effect of orlistat on body weight and coronary heart disease risk profile in obese patients: The Swedish Multimorbidity Study. J Intern Med 2000; 248: 245-54. PubMed
- Dombrowski SU, Knittle K, Avenell A, et al. Long term maintenance of weight loss with non-surgical interventions in obese adults: systematic review and meta-analyses of randomised controlled trials. BMJ. 2014 May 14;348:g2646. doi: 10.1136/bmj.g2646. DOI
- Greenway FL, Fujioka K, Plodkowski RA, et al. Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 2010; 376: 595-605. PubMed
- Apovian CM, Aronne L, Rubino D et al; COR-II Study Group. A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II). Obesity 2013; 21: 935-43. pmid:23408728 PubMed
- Wadden TA, Foreyt JP, Foster GD et al. Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trial. Obesity 2011; 19: 110-20. pmid:20559296 PubMed
- Hollander P, Gupta AK, Plodkowski R, et al; COR-Diabetes Study Group. Effects of naltrexone sustained-release/bupropion sustained-release combination therapy on body weight and glycemic parameters in overweight and obese patients with type 2 diabetes. Diabetes Care 2013; 36: 4022-29. pmid:24144653 PubMed
- Isaacs D, Prasad-Reddy L, Srivastava SB. Role of glucagon-like peptide 1 receptor agonists in management of obesity. Am J Health Syst Pharm. 2016 Oct 1;73(19):1493-507. PMID: 27521241. PubMed
- Astrup A, Rössner S, Van Gaal L, et al. Effects of luraglitide in the treatment of obesity: a randomised, double-blind, placebo-controlled study. Lancet 2009; 374: DOI:10.1016/S0140-6736(09)61375-1. DOI
- Wilding J, Batterham R, Calanna S et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med 2021; 384:989-1002 New England Journal of Medicine
- Shi Q, Wang Y, Hao Q, et al. Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials. Lancet 2021. pmid:34895470 PubMed
- Weghuber D, Barrett T, Barrientos-Pérez M, et al. Once-Weekly Semaglutide in Adolescents with Obesity. N Engl J Med 2022. pmid:36322838 PubMed
- Curioni C, André C. Rimonabant for overweight or obesity. Cochrane Database of Systematic Reviews, issue 2, 2007. The Cochrane Library
- Courcoulas AP, Yanovski SZ, Bonds D, et al. Long-term outcomes of bariatric surgery: a National Institutes of Health symposium. BMJ. 2015 Jan 5;350:g6380. PMID: 25271405. PubMed
- Ollendorf DA, Cameron CG, Pearson SD. Effectiveness and Value of Treatment Options for Obesity-A Report for the California Technology Assessment Forum. JAMA Intern Med. 2016 Feb;176(2):247-8. doi: 10.1001/jamainternmed.2015.7189. PMID: 26746682 PubMed
- Ikramuddin S, Korner J, Lee WJ, et al. Lifestyle Intervention and Medical Management With vs Without Roux-en-Y Gastric Bypass and Control of Hemoglobin A1c, LDL Cholesterol, and Systolic Blood Pressure at 5 Years in the Diabetes Surgery Study. JAMA 2018; 319: 266-78. pmid:29340678 PubMed
- Reges O, Greenland P, Dicker D, et al. Association of Bariatric Surgery Using Laparoscopic Banding, Roux-en-Y Gastric Bypass, or Laparoscopic Sleeve Gastrectomy vs Usual Care Obesity Management With All-Cause Mortality. JAMA 2018; 319: 279-90. pmid:29340677 PubMed
- Merlotti C, Morabito A, Pontiroli AE. Prevention of type 2 diabetes: a systematic review and meta-analysis of different intervention strategies. Diabetes Obes Metab 2014; 16: 719-27. pmid:24476122 PubMed
- Jakobsen GS, Småstuen MC, Sandbu R, et al. Association of bariatric surgery vs medical obesity treatment with long-term medical complications and obesity-related comorbidities. JAMA 2018; 319: 291-301. pmid:29340680 PubMed
- Peterli R, Wölnerhanssen BK, Peters T, et al. Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss in Patients With Morbid Obesity: The SM-BOSS Randomized Clinical Trial. JAMA 2018; 319: 255-65. pmid:29340679 PubMed
- Salminen O, Helmiö M, Ovaska J, et al. Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss at 5 Years Among Patients With Morbid Obesity: The SLEEVEPASS Randomized Clinical Trial. JAMA 2018; 319: 241-54. pmid:29340676 PubMed
- Giske L, Stoinska-Schneider A, Arentz-HansenA et al. Fedmekirurgi ved diabetes type 2 og kroppsmasseindeks under 35. Rapport - 2018. Oslo: Folkehelseinstituttet; 2018. www.fhi.no
- O'Brien PE, Dixon JB, Laurie C et al. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial. Ann Intern Med 2006; 144: 625-33. PMID: 16670131 PubMed
- Trus TL, Pope GD, Finlayson SR. National trends in utilization and outcomes of bariatric surgery. Surg Endosc 2005; 19: 616–20.
- DuPree CE, Blair K, Steele SR, Martin MJ. Laparoscopic sleeve gastrectomy in patients with preexisting gastroesophageal reflux disease. JAMA Surg 2014 PMID: 24500799 PubMed
- Andreasson K, Videhult P. Gastrisk bypass eller sleeve-gastrektomi – vilken är bäst? Läkartidningen. 2017;114:ER3H lakartidningen.se
- Søvik TT, Aasheim ET, Taha O, et al. Weight loss, cardiovascular risk factors, and quality of life after gastric bypass and duodenal switch. Ann Intern Med 2011; 155: 281-91. Annals of Internal Medicine
- Pedersen SB, Møller D, Funch-Jensen PM. Kirurgisk behandling af svær fedme. Ugeskr Læger 2005; 167: 1942-5. PubMed
- Nguyen NT, Slone JA, Nguyen XM, Hartman JS, Hoyt DB. A Prospective Randomized Trial of Laparoscopic Gastric Bypass Versus Laparoscopic Adjustable Gastric Banding for the Treatment of Morbid Obesity: Outcomes, Quality of Life, and Costs. Ann Surg 2009; 250: 631. PubMed
- Dayyeh BKA, Maselli DB, Rapaka B, et al. Adjustable intragastric balloon for treatment of obesity: a multicentre, open-label, randomised clinical trial. Lancet 2021. pmid:34793746 PubMed
- Crossan K, Sheer AJ. Intragastric Balloon. 2022 Jun 9. In: StatPearls Internet. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. PMID: 35201712 PubMed
- Abu Dayyeh BK, Bazerbachi F, Vargas EJ, et al. Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): a prospective, multicentre, randomised trial. Lancet. 2022;400(10350):441-451. doi:10.1016/S0140-6736(22)01280-6. PMID: 35908555 PubMed
- Schiavon CA, Bersch-Ferreira AC, Santucci EV. Effects of Bariatric Surgery in Obese Patients With Hypertension: The GATEWAY Randomized Trial (Gastric Bypass to Treat Obese Patients With Steady Hypertension). Circulation 2017. pmid:29133606 PubMed
- Murphy R, Plank LD, Clarke MG, et al . Effect of Banded Roux-en-Y Gastric Bypass Versus Sleeve Gastrectomy on Diabetes Remission at 5 Years Among Patients With Obesity and Type 2 Diabetes: A Blinded Randomized Clinical Trial.. Diabetes Care 2022; 45: 1503-11. pmid:35554515 PubMed
- Sjostrom L, Narbro K, Sjostrom CD, et al, for the Swedish Obese Subjects Study. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007; 357: 741-52. New England Journal of Medicine
- O'Brien PE, Sawyer SM, Laurie C, et al. laparoscopic adjustable gastric banding in severely obese adolescents. JAMA 2010; 303: 519-26. PMID: 20145228 PubMed
- Chang SH, Stoll CR, Song J, et al. The effectiveness and risks of bariatric surgery: An updated systematic review and meta-analysis, 2003-2012. JAMA Surg 2013. PMID: 24352617 PubMed
- ArterburnDE, Olsen MK, Smith VA, et al. Association between bariatric surgery and longterm survival. JAMA 2015; 313: 62-70. PMID: 25562267 PubMed
- Syn NL, Cummings DE, Wang LZ, et al. Association of metabolic-bariatric surgery with long-term survival in adults with and without diabetes: A one-stage meta-analysis of matched cohort and prospective controlled studies with 174 772 participants.. Lancet 2021; 397: 1830. pmid:33965067 PubMed
- Rask E, Peters H, Jansson S. Hypoglykemi – problematisk komplikation av överviktskirurgi Hypoglycemia following gastric bypass surgery - a case, causes and coping. Lakartidningen. 2019;116:FHFP. Published 2019 Feb 19.PMID: 31192390 PubMed
- Scarpellini E, Arts J, Karamanolis G, et al. International consensus on the diagnosis and management of dumping syndrome. Nat Rev Endocrinol. 2020;16(8):448-466. doi:10.1038/s41574-020-0357-5PMID: 32457534 PubMed
- Buksmärtor vanliga efter fetmakirurgi. Janusinfo. Region Stockholm. Hämtad 20201201 janusinfo.se
- Fisher SA, Stetson BT, Kominiarek MA. Pregnancy After Bariatric Surgery. JAMA. 2023 Feb 10. Epub ahead of print. PMID: 36763352 PubMed
- Följ upp läkemedel efter fetmakirurgi. Janusinfo. Region Stockholm. Hämtad 2020-12-01 janusinfo.se
- Anna Nager, med dr och specialist i allmänmedicin, Karolinska institutet